Congratulations to Daniel Herranz Benito, Ph.D., on earning more than 2 million in grants to study T-cell acute lymphoblastic leukemia (T-ALL). Read more here. Herranz, who was funded by the Leukemia Research Foundation in 2018, is a member of the Cancer Pharmacology Program at Rutgers Cancer
Congratulations to Craig A. Mullen, M.D., Ph.D. and colleagues at the Golisano Children’s Hospital at the University of Rochester Medical Center, on receiving a 100,000 grant from Hyundai Hope on Wheels to study childhood cancer treatments. The research will focus on leukemia, the most commonly
Michael Kharas, Ph.D., associate member of the Molecular Pharmacology at the Memorial Sloan Kettering Cancer Center in New York and colleagues are investigating how chemical markers on genes impact cell development and differentiation. Controlling the chemical markers can help to kill tumor
Congratulations to Nancy A. Speck, Ph.D. from Perelman School of Medicine at the University of Pennsylvania, who was recently elected to the National Academy of Sciences, one of the highest honors that a scientist can receive. Read more here. Speck, who was funded by the Leukemia Research
Maria E. Figueroa, M.D. and colleagues recently published research findings about cellular aging and the risk of developing cancer, including blood cancers. Read more here. Doctor Figueroa was funded by the Leukemia Research Foundation in 2012.
Wei Du, M.D., Ph.D. and colleagues may have found a link between how stem cells make energy and Fanconi anemia, a disease that is usually diagnosed in children, who sometimes develop leukemia. Doctor Du’s findings could not only improve treatment but
Iannis Aifantis, Ph.D., professor and chair of the Department of Pathology at the Perlmutter Cancer Center at NYU Langone Health, and colleagues have discovered how rare blood cell types within the bone marrow microenvironment function. Understanding